Results 71 to 80 of about 2,103,170 (215)
Co-Catalytic Metallopeptidases as Pharmaceutical Targets [PDF]
, 2003 Understanding the reaction mechanism of co-catalytic metallopeptidases provides a starting point for the design and synthesis of new molecules that can be screened as potential pharmaceuticals. Many of the enzymes that contain co-catalytic metallo-active
Bzymek, Krzysztof P. +2 more
core +2 more sources
Pharmaceutics for the anaesthetist [PDF]
Anaesthesia, 2001 Pharmaceutics is that branch of science concerned with the manufacture and formulation of pharmaceutical products, and is a subject almost exclusively in the domain of pharmacists and those concerned with pharmaceutical manufacture. However, there are some aspects of pharmaceutics that are of particular importance to the anaesthetist, such as the ...
openaire +2 more sources
Archives of Anesthesia and Critical CareBackground: This double-blind clinical trial aimed to investigate the effectiveness of splanchnic nerve blocks using different medication combinations on pain severity and duration of pain relief in patients with pancreatic cancer-related abdominal pain.
Alireza Khajehnasiri +4 more
doaj +1 more source
Strategic Development Trends in the World Pharmaceutical Industry [PDF]
The main purpose of the paper is to research and evaluate the strategic development trends in the world pharmaceutical industry in the period 1996–2006.We aim to find that mergers and acquisitions prevail as a vital strategic development option in the ...
Dragan Kesic
core
Pharmaceutically Active Compound (PhAC) Degradation by Means of Cold Plasma Jet Treatment
PlasmaThe occurrence of emerging micropollutants of pharmaceutically active compounds (PhACs) in the environment poses a public health concern. Due to PhAC persistence and toxicity even at low concentrations, advanced oxidation processes (AOPs) have gained ...
Alkistis Kanteraki +5 more
doaj +1 more source
Fruit Pod Extracts as a Source of Nutraceuticals and Pharmaceuticals
Molecules, 2012 Fruit pods contain various beneficial compounds that have biological activities and can be used as a source of pharmaceutical and nutraceutical products.
Azrina Azlan, Azila Abdul Karim
doaj +1 more source
Crystal structure of (S)-5-(3-acetyl-5-chloro-2-ethoxy-6-fluorophenyl)-2-oxazolidinone
Acta Crystallographica Section E: Crystallographic CommunicationsThe structure of (S)-5-(3-acetyl-5-chloro-2-ethoxy-6-fluorophenyl)-2-oxazolidinone, C13H13ClFNO4, at 100 K has monoclinic (P21) symmetry. The compound has a polymeric structure propagated by a screw axis parallel to the b axis with N—H...O hydrogen ...
Victor Li, Glenn P. A. Yap, Chaoying Ni
doaj +1 more source
Pharmaceutical Marketing in the Sanitary-Veterinary Sector [PDF]
The paper discusses the particular problems marketing practice encounters in the pharmaceutical sector, investigating some of their underlying causes. The span of the pharmaceutical sector is then restricted to veterinary pharmaceutical marketing, as a ...
Mihaela Cornelia Prejmerean +1 more
core
A method of assessing the quality of pharmaceutical market and industry reports as a source to study access to medicines [PDF]
, 2016 This repository item contains a single issue of the Health and Development Discussion Papers, an informal working paper series that began publishing in 2002 by the Boston University Center for Global Health and Development.
Knox, Ryan P. +2 more
core +1 more source
The Unexpected Impact of Information-Sharing on US Pharmaceutical Supply-Chains [PDF]
This paper examines the introduction of information-sharing into the supply chains for pharmaceutical products in the United States. This introduction was unusual for several reasons. First, it was catalyzed from outside the industry, by a Securities and
Hui Zhao, Leroy B. Schwarz
core